(WWSB) - 35 years ago, a pair of scientists made a discovery that they believed would change Alzheimer’s research forever.

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. Research on ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

Leqembi’s rollout has been slowed by bottlenecks related to reimbursement uncertainties, diagnostic test requirements and ...

The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...

This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...

Bre Teamer chats with Dr. Alex Zayid of Icon Anti-Aging about recent developments and research that supports using ...

Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and ...

Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...